Walleye Capital LLC Voyager Therapeutics, Inc. Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$7.55 - $11.25 $1.03 Million - $1.54 Million	-136,766 Reduced 91.16%	13,262 $102,000
Q2 2023 Aug 14, 2023	BUY	$6.94 - $13.99 $1.04 Million - $2.1 Million	150,028 New	150,028 $1.72 Million
Q3 2022 Nov 14, 2022	BUY	$5.57 - $7.47 $490,761 - $658,166	88,108 Added 226.46%	127,014 $752,000
Q2 2022 Aug 08, 2022	SELL	$4.82 - $10.09 $538,688 - $1.13 Million	-111,761 Reduced 74.18%	38,906 $230,000
Q1 2022 May 16, 2022	BUY	$2.75 - $9.44 $414,334 - $1.42 Million	150,667 New	150,667 $1.15 Million
Q4 2021 Mar 03, 2022	SELL	$2.47 - $5.55 $39,690 - $89,182	-16,069 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.63 - $4.12 $42,261 - $66,204	16,069 New	16,069 $42,000

135

34.4M

60.4K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $150M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.